close

Enter

Log in using OpenID

Over-the-Counter Drugs Market Growth And Future Outlook By 2026

embed
Over-the-counter drugs, also known as non-prescription drugs, are available in pharmacies and other retail stores and can be used without being prescribed by a doctor.
Over-the-Counter Drugs Market Growth And Future
Outlook By 2026
Over-the-counter drugs, also known as non-prescription drugs, are available in pharmacies and
other retail stores and can be used without being prescribed by a doctor. These drugs are
critical components of the pharmaceutical industry as they are highly potent and have the
capability to show effective results for simple diseases. The number of competitors diving into
the large pool of pharmaceutical industry are increasing day-by-day making the industry a
promising venture for new comers to capitalize upon. This review will help to attain a
competitive analysis of developments such as strategic alliances, mergers and acquisition, joint
ventures as well research and innovation leading to product development with respect to overthe-counter drugs market. According to Consumer Healthcare Products Association, the total
U.S. sales for OTC medicines accounted for US$ 34,327 million in 2017.
Request Sample Copy of Research Report @
https://www.coherentmarketinsights.com/insight/request-sample/1443
Competitive Analysis - The top 10 players operating in the global over-the-counter drugs market
include:
1. Pfizer, Inc. - Pfizer, Inc. is a global leading manufacturer and distributor of over-the-
counter drugs, managing its commercial operation through two major business segments
namely, Pfizer Innovative Health and Pfizer Essential Health. OTC drugs contribute to a
major part of Innovative Health Segment, comprising annual revenue of US$ 29,197
million in 2016. The company OTC drugs portfolio includes over 40 products, whereas
the leading OTC brands that generated significant revenue for Pfizer included Advil
(Ibuprofen capsules for migraine) and Centrum (Multivitamin Tablets), in 2016. Moreover,
the company collaborated for the license of Nexium OTC rights under the exclusive
agreement with AstraZeneca Plc made in 2012, Pfizer paid US$ 93 Mn to AstraZeneca in
April, 2016 as accrued milestone payments as per the norms of the agreement. Pfizer,
Inc. adopts strategies such as entering into partnerships and collaborations with
companies that adopts incorporation of novel, proprietary drug-delivery technologies as
well as unique ingredients of the OTC drugs to expand their OTC product portfolio to
retain their significance in global over-the-counter drugs market.
Novartis AG - Novartis AG, is widely known for its research, development, manufacturing, and
marketing of healthcare products across the globe. Novartis operates its drugs business through
two major operating channels Innovative Medicine and Drugs manufactured by Sandoz which is
a subsidiary of Novartis, has contributed to positioning the company as one of the top players
in global Over-the-counter drugs market. In March 2015, Novartis OTC and GlaxoSmithKline Plc
created a combined consumer healthcare business named GlaxoSmithKline Consumer Healthcare
Holdings Ltd, as a completely new entity, for which Novartis has an interest of 36.5% in the
investment and profit shares and the resulting pre-tax income from this alliance was valued at
US$ 5.9 billion in 2016. The company also markets and manufactures its products through
Sandoz. Sandoz specializes in OTC medications for allergy and pain relief and is available in
pharmacies across the world. The channel focuses on business expansion and distribution in the
Central & Eastern Europe region, including Germany, as the company believes European region
to be an integral part of the business and a potential market for growth of company’s business.
Report includes chapters which deeply display the following deliverable about industry :
• Over-the-Counter Drugs Market Research Objective and Assumption
• Over-the-Counter Drugs Market Purview - Report Description, Executive Summary, and
Coherent Opportunity Map (COM)
• Over-the-Counter Drugs Market Dynamics, Regulations, and Trends Analysis - Market
Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system
Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Over-the-Counter Drugs Market, By Regions
• Over-the-Counter Drugs Market Competition by Manufacturers including Production, Share,
Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Over-the-Counter Drugs Market Manufacturers Profiles/Analysis including Company Basic
Information, Manufacturing Base and Its Competitors.
• Over-the-Counter Drugs Market Manufacturing Cost Analysis including Key Raw Materials and
Key Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Over-the-Counter Drugs Market Forecast including Production, Consumption, Import and
Export Forecast by Type, Applications and Region.
• Research Findings and Conclusion
2. GlaxoSmithKline Plc - GlaxoSmithKline, one of the renowned giant in pharmaceutical
industry and over-the-counter drugs market is a global science-led company
headquartered in Europe, which develops and manufactures pharmaceutical products,
including vaccines, health-related consumer products, and over-the-counter medicines. The
consumer healthcare business of GlaxoSmithKline is operated through its subsidiary named
GlaxoSmithKline Consumer Healthcare Holdings Ltd. the subsidiary is split into two equal
businesses, namely Over-the-counter Medicines and Fast Moving Consumer Goods (FMCG),
across four major categories of Oral Health, Wellness, Skin Health, and Nutrition. The
company’s consumer healthcare business segment recorded annual sales of US$ 5,023
million in 2016, of which Europe contributed to the major share of around 30.4%, with
U.S. accounting for 24.4% of the share. The company adopts strategy of expanding the
business in a growing marketplace thereby developing products that responds to the
challenges in Over-the-counter drugs sector that includes educating the users to prevent
adverse side effects of these drugs when consumed inappropriately and others. The
company also focusses on providing products at a sustainable price to help increase
customer adoption and allow access to several patients around the world.
Browse Complete Report For More Information @
https://www.coherentmarketinsights.com/ongoing-insight/over-the-counter-drugs-market-globalcompetitive-analysis-1443
3. Bayer AG - Bayer AG is a global life science company that has a history of over 150
years in areas of healthcare and agriculture. The company operates its business through
four major segments namely, Pharmaceuticals, Consumer Health, Crop Science, and
Animal Health. Over-the-counter drugs contribute to a major revenue share of the
consumer health segment, which accounted for US$ 7,179.19 million in 2016. The
company caters to the users of over-the-counter drugs market through Consumer Health
segment that includes major non-prescription drugs and products in the dermatology,
gastrointestinal, analgesic, cold, allergy, and sinus, and sun protection categories. The
consumer health segment is responding to the challenge in public health care system with
mainly non-prescription (OTC) brand products by providing the consumers with their
corresponding self-care solutions that are easily available at the pharmacies and online
drug stores. The core brands leading to organic growth of the company’s segment include
Aspirin, Aleve, Canesten, Dr. Scholls, Coppertone, Elevit, Bepanthen, Alka-Seltzer, and
Berocca. The company is investing in geographical expansion to strengthen its presence in
the U.S. Brazil, Russia, and China through marketing innovations and novel digital
offerings. For instance, the company introduced a number of new product line extensions
in the U.S. of its existing brands, including ClariSpray in the Claritin portfolio added in
April, 2016. The extension of Alka-Seltzer product family with the addition of AlkaSeltzer Plus as an OTC medicine for treatment of cold. Successful strategic
implementation and new product development by the company is expected to significantly
affect the growth of global over-the-counter drugs market.
4. Sanofi - Sanofi is a global life science company based in France (Europe) that is aimed
towards improving healthcare access to people. The company operates its business
through two major segments namely, Pharmaceuticals and Vaccines. The company
operates its over-the-counter business as a part of a major business segment named
Consumer Healthcare (CHC). Sanofi focuses on partnerships and acquisitions to expand its
consumer healthcare business. For instance, Sanofi completed acquisition of Boehringer
Ingelheim’s CHC business in 2017, expand the company’s global footprint and product
portfolio. In February 2017, Sanofi sold 5 of its over-the-counter drugs to Ipsen SA on
closure of its asset swap with Boehringer Ingelheim GmbH. Ipsen SA was entitled for a
payment of US$ 98.70 million to purchase the deal from Sanofi. The total revenue of the
company’s consumer healthcare segment was valued at US$ 4,141.31 million in 2016.
The company reported of good performance and growing sales in developing regions such
as New Zealand and Australia. The major brands in the company’s OTC segment include
Allegra, Doliprane, Essentiale, Nasacort, Maalox, Dorflex, and Lactacyd
To Get Instant Access, Purchase Report Here @ https://www.coherentmarketinsights.com/insight/
buy-now/1443
The global over-the-counter drugs market is highly competitive, owing to increasing adoption of
personal healthcare and self-medication due to rising awareness among the people regarding
health precautions and basic drug knowledge. Under such conditions, the competitors experience
performance pressure in terms of pricing. Market players are thus focusing on development of
OTC drugs in cost-effective way that will help to cater price-sensitive customers, in turn,
significantly maintain and subsequently increase profit margins, especially in emerging
economies.
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering actionready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]tinsights.com
Author
Alex Huge
Alex Huge339   documents Email
Document
Category
Health and Medicine
Views
1
File Size
142 KB
Tags
Over-the-Counter Drugs Market
1/--pages
Report inappropriate content